Use of the vial equilibration technique for determination of metabolic rate constants for dichloromethane

Toxicology and Applied Pharmacology

Volumn 139, Issue 2, 1996, Pages 243-251

  Kim, C ^a,c   Manning, R O ^a,d   Brown, R P ^b   Bruckner, J V ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c Bukwang Pharmaceutical Company   (South Korea)

^d Environmental Protection Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 ISOENZYME; DICHLOROMETHANE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG METABOLISM; GAS CHROMATOGRAPHY; LIVER HOMOGENATE; LIVER METABOLISM; MALE; METABOLIC RATE; NONHUMAN; RAT; TECHNIQUE;

ANIMALIA;

EID: 0030220583     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0163     Document Type: Article

References (36)

1. Anders, M. W. (1978). Inhibition and enhancement of microsomal drug metabolism by diethyl maleate. Biochem. Pharmacol. 27, 1098-1101.
2. Anders, M. W., Kubic, V. L., and Ahmed, A. E. (1977). Metabolism of halogenated methanes and macromolecular binding. J. Environ. Pathol. Toxicol. 1, 117-124.
3. Andersen, M. E., Clewell, H. J., III, Gargas, M. L., Smith, F. A., and Reitz, R. H. (1987). Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol. 87, 185-205.
4. Andersen, M. E., Clewell, H. J., III., Gargas, M. L., MacNaughton, M. G., Reitz, R. H., Nolan, R. J., and McKenna, M. J. (1991). Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans. Toxicol. Appl. Pharmacol. 108, 14-27.
5. ATSDR (1993). Toxicological Profile for Methylene Chloride. TP-92/13, Agency for Toxic Substances and Disease Registry, U.S. Public Health Service, Atlanta, GA.
6. Burek, J. D., Nitschke, K. D., Bell, T. J., Wackerle, D. L., Childs, R. C., Beyer, J. E., Dittenber, D. A., Rampy, L. W., and McKenna, M. J. (1984). Methylene chloride: A 2-year inhalation toxicity and oncogenicity study in rats and hamsters. Fundam. Appl. Toxicol. 4, 30-47.
7. Clejan, L. A., and Cederbaum, A. I. (1990). Oxidation of pyrazole by reconstituted systems containing cytochrome P-450 IIE1. Biochem. Biophys. Acta 1034, 233-237.
8. Gargas, M. L., Clewell, H. J., III, and Andersen, M. E. (1986). Metabolism of inhaled dichloromethane in vivo: Differentiation of kinetic constants for two independent pathways. Toxicol. Appl. Pharmacol. 82, 211-223.
9. Gargas, M. L., Burgess, R. J., Voisard, D. E., Cason, G. H., and Andersen, M. E. (1989). Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol. Appl. Pharmacol. 98, 87-99.
10. Guengerich, F. P., Kim, D.-H., and Iwasaki, M. (1991). Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4, 168-179.
11. Habig, W. H., Pabst, M. J., and Jakoby, W. B. (1974). Glutathione S-transferase: The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 19, 1-20.
12. Hansson, T., Tindberg, N., Ingelman-Sundberg, M., and Kohler, C. (1990). Regional distribution of ethanol-inducible cytochrome P-450 IIE1 in the rat central nervous system. Neuroscience 34, 451-463.
13. Hetrick, D. M., Jarabek, A. M., and Travis, C. C. (1991). Sensitivity analysis for physiologically based pharmacokinetic models. J. Pharmacokin. Biopharm. 19, 1-20.
14. Koop, D. R. (1992). Oxidative and reductive metabolism by cytochrome P-450 2E1. FASEB J. 6, 724-730.
15. Koop, D. R., Crump, B. L., Nordblom, G. D., and Coon, M. J. (1985). Immunochemical evidence for induction of the alcohol-oxidizing cytochrome P-450 of rabbit liver microsomes by diverse agents: Ethanol, imidazole, trichloroethylene, acetone, pyrazole, and isoniazid. Proc. Natl. Acad. Sci. 82, 4065-4069.
16. Kubic, V. L., and Anders, M. W. (1978). Metabolism of dihalomethane to carbon monoxide. Studies on the mechanism of the reaction. Biochem. Pharmacol. 27, 2349-2355.
17. Lineweaver, H., and Burk, D. (1934). The determination of enzyme dissociation constants. J. Am. Chem. Soc. 56, 658-666.
18. Lorenz, J., Glatt, H. R., Fleischmann, R., Ferlinz, R., and Oesch, F. (1984). Drug metabolism in man and its relationship to that in three rodent species: Monooxygenase, epoxide hydrolyase, and glutathione S-transferase activities in subcellular fractions of lung and liver. Biochem. Med. 32, 43-56.
19. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurements with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
20. 1 mice. Ann. N.Y. Acad. Sci. 534, 343-351.
21. Murray, M. (1988). Complexation of cytochrome P-450 isozymes in hepatic microsomes from SKF-525A-induced rats. Arch. Biochem. Biophys. 262, 381-388.
22. Netter, K. J., Kahl, G.-F., and Magnussen, M. P. (1969). Kinetic experiments on the binding of metyrapone to liver microsomes. Naunyn-Schm. Arch. Pharmakol. 265, 205-215.
23. Omura, T., and Sato, R. (1964). The carbon monoxide-binding pigment of liver microsomes. J. Biol. Chem. 239, 2370-2378.
24. Peterson, J. E. (1975). Modeling the uptake, metabolism and excretion of dichloromethane by man. Am. Ind. Hyg. Assoc. J. 39, 41-47.
25. Reitz, R. H., Mendrala, A. L., Park, C. N., Andersen, M. E., and Guengerich, F. P. (1988). Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PB-PK) model for methylene chloride: Implications for risk assessment. Toxicol. Lett. 43, 97-116.
26. Reitz, R. H., Mendrala, A. L., and Guengerich, F. P. (1989). In vitro metabolism of methylene chloride in human and animal tissues: Use in physiologically based pharmacokinetic models. Toxicol. Appl. Pharmacol. 97, 230-246.
27. Sato, A., and Nakajima, T. (1979a). A vial-equilibration method to evaluate the drug-metabolizing enzyme activity for volatile hydrocarbons. Toxicol. Appl. Pharmacol. 47, 41-46.
28. Sato, A., and Nakajima, T. (1979b). A structure-activity relationship of some chlorinated hydrocarbons. Arch. Environ. Health 34, 69-75.
29. Sato, A., and Nakajima, T. (1979c). A structure-activity relationship of some chlorinated hydrocarbons. Brit. J. Ind. Med. 36, 231-234.
30. Schenkman, J. B., Wilson, B. J., and Cinti, D. L. (1972). Diethylaminoethyl 2,2-diphenylvalerate HCl (SKF 525-A)-in vivo and in vitro effects of metabolism by rat liver microsomes - Formation of an oxygenated complex. Biochem. Pharmacol. 21, 2373-2383.
31. Siegers, C. P., Horn, W., and Younes, M. (1985). Effect of phorone-induced glutathione depletion on the metabolism and hepatotoxicity of carbon tetrachloride and vinylidene chloride in rats. J. Appl. Toxicol. 5, 352-356.
32. Stewart, R. D., Fisher, T. N., Hosko, M. J., Peterson, J. E., Baretta, E. D., and Dodd, H. C. (1972). Experimental human exposure to methylene chloride. Arch. Environ. Health 25, 342-348.
33. U.S. EPA (1985). Occupational Exposure and Environmental Release Assessment of Methylene Chloride. Office of Drinking Water, Environmental Protection Agency, Washington, DC.
34. Van Doom, R., Leijdekkers, CH-. M., and Henderson, P. T. H. (1978). Synergistic effects of phorone on the hepatotoxicity of bromobenzene and paracetamol in mice. Toxicology 11, 225-233.
35. Winters, D. K., and Cederbaum, A. I. (1990). Oxidation of glycerol to formaldehyde by rat liver microsomes. Effects of cytochrome P-450 inducing agents. Biochem. Pharmacol. 39, 697-705.
36. Yoo, J.-S. H., Cheung, R. J., Pattern, C. J., Wade, D., and Yang, S. S. (1987). Nature of N-nitrosodimethylamine demethylase and its inhibitors. Cancer Res. 47, 3378-3383.